Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading AXSM News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.81%15.7814.2%$301.90m
SHPGShire PLC Sponsored ADR
-1.11%172.980.4%$213.79m
PRGOPerrigo Co. Plc
0.83%75.276.4%$143.86m
PRXLPAREXEL International Corporation
-0.36%86.807.9%$136.24m
MNKMallinckrodt Plc
2.12%46.3317.7%$126.60m
ALRAlere Inc.
-0.10%50.182.7%$93.63m
JAZZJazz Pharmaceuticals Plc
-0.43%158.802.2%$84.49m
UTHRUnited Therapeutics Corporation
-0.08%131.5913.9%$76.26m
ENDPEndo International Plc
1.63%11.848.9%$73.99m
PTLAPortola Pharmaceuticals, Inc.
46.75%56.138.9%$69.62m
HZNPHorizon Pharma plc
-1.22%11.737.6%$57.17m
AERIAerie Pharmaceuticals, Inc.
-0.45%54.808.9%$55.00m
ICPTIntercept Pharmaceuticals, Inc.
1.32%132.2922.1%$52.53m
MDCOMedicines Company
1.18%38.6022.3%$51.68m
CTLTCatalent Inc
-1.53%37.222.8%$40.04m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.,00FKGV-E